In December 2011, U.S. Representatives Cliff Stearns (R-FL) and Ed Towns (D-NY), two senior members of the Energy and Commerce Committee, introduced bipartisan legislation to help spur the development of treatments for very rare diseases.
The Unlocking Lifesaving Treatments for Rare Diseases Act of 2012, or ULTRA, H.R. 3737, will improve access to the FDA’s Accelerated Approval process for very rare diseases, provide a more predictable regulatory process, bring down development costs, and spur investment in the development of treatments.
Additionally, ULTRA requires the FDA to use the best science available, ensuring treatments are safe and effective and reach patients sooner.
Over 90 organizations have signed on to the letters of support.
Visit CureTheProcess.org for more information.